AC Immune SA Price to Sales Ratio 2016-2019 | ACIU

Historical PS ratio values for AC Immune SA (ACIU) over the last 10 years. The current P/S ratio for AC Immune SA as of July 15, 2019 is .
AC Immune SA P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-07-15 5.51 4.79
2019-03-31 5.05 $1.15 4.39
2018-12-31 9.45 $0.12 77.67
2018-09-30 8.00 $0.39 20.44
2018-06-30 9.32 $0.37 24.86
2018-03-31 10.34 $0.35 29.34
2017-12-31 12.80 $0.36 35.48
2017-09-30 11.17 $0.09 118.05
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.365B $0.007B
AC Immune SA is a biopharmaceutical company. It develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn which are in clinical trial. AC Immune SA is based in Lausanne, Switzerland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $106.696B 12.06
Gilead Sciences (GILD) United States $84.475B 10.26
Celgene (CELG) United States $64.835B 10.98
Vertex Pharmaceuticals (VRTX) United States $45.024B 54.42
Biogen (BIIB) United States $44.871B 8.52
Illumina (ILMN) United States $44.842B 51.97
CSL (CSLLY) Australia $34.985B 0.00
Regeneron Pharmaceuticals (REGN) United States $31.970B 15.03
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.092B 15.33
Incyte (INCY) United States $17.177B 69.65
BioMarin Pharmaceutical (BMRN) United States $14.854B 0.00
Exact Sciences (EXAS) United States $14.834B 0.00
SINO PHARMACEUT (SBMFF) China $13.649B 0.00
Sarepta Therapeutics (SRPT) United States $11.575B 0.00
Genmab (GNMSF) Denmark $11.320B 57.55
Array BioPharma (ARRY) United States $10.411B 0.00
Seattle Genetics (SGEN) United States $10.289B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $8.950B 29.40
Bio-Techne Corp (TECH) United States $7.927B 54.08
Alnylam Pharmaceuticals (ALNY) United States $7.622B 0.00
Guardant Health (GH) United States $7.527B 0.00
Galapagos (GLPG) Belgium $7.468B 0.00
Bluebird Bio (BLUE) United States $7.312B 0.00
Amarin (AMRN) Ireland $7.239B 0.00
Exelixis (EXEL) United States $6.331B 16.14
BeiGene (BGNE) Cayman Islands $5.723B 0.00
Ascendis Pharma (ASND) Denmark $4.747B 0.00
Moderna (MRNA) United States $4.672B 0.00
Blueprint Medicines (BPMC) United States $4.641B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.479B 0.00
Horizon Pharma Public (HZNP) Ireland $4.337B 11.17
Repligen (RGEN) United States $4.014B 100.00
ACADIA Pharmaceuticals (ACAD) United States $3.926B 0.00
Mirati Therapeutics (MRTX) United States $3.811B 0.00
Spark Therapeutics (ONCE) United States $3.766B 0.00
China Biologic Products (CBPO) China $3.677B 23.35
Alkermes (ALKS) Ireland $3.535B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.365B 0.00
MorphoSys AG (MOR) Germany $3.223B 0.00
Arena Pharmaceuticals (ARNA) United States $3.048B 6.19
Amicus Therapeutics (FOLD) United States $2.858B 0.00
Immunomedics (IMMU) United States $2.810B 0.00
Medicines (MDCO) United States $2.716B 0.00
UniQure (QURE) Netherlands $2.658B 0.00
Reata Pharmaceuticals (RETA) United States $2.612B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.598B 0.00
Halozyme Therapeutics (HALO) United States $2.413B 0.00
Akcea Therapeutics (AKCA) United States $2.351B 0.00
MyoKardia (MYOK) United States $2.340B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.338B 0.00
Ligand Pharmaceuticals (LGND) United States $2.282B 18.90
Emergent Biosolutions (EBS) United States $2.223B 19.31
Acceleron Pharma (XLRN) United States $2.153B 0.00
Zai Lab (ZLAB) China $2.112B 0.00
NeoGenomics (NEO) United States $2.112B 138.25
Genomic Health (GHDX) United States $2.086B 44.31
Intercept Pharmaceuticals (ICPT) United States $2.076B 0.00
Denali Therapeutics (DNLI) United States $1.911B 0.00
Myriad Genetics (MYGN) United States $1.887B 18.77
Insmed (INSM) United States $1.765B 0.00
REGENXBIO (RGNX) United States $1.740B 0.00
Cambrex (CBM) United States $1.485B 18.78
AnaptysBio (ANAB) United States $1.474B 0.00
Innoviva (INVA) United States $1.432B 3.96
Fate Therapeutics (FATE) United States $1.404B 0.00
RA PHARMCTL INC (RARX) United States $1.399B 0.00
Sangamo Therapeutics (SGMO) United States $1.352B 0.00
Athenex (ATNX) United States $1.340B 0.00
Coherus BioSciences (CHRS) United States $1.333B 0.00
Alector (ALEC) United States $1.276B 0.00
Epizyme (EPZM) United States $1.246B 0.00
Editas Medicine (EDIT) United States $1.223B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.165B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.078B 0.00
Codexis (CDXS) United States $1.037B 0.00
ANI Pharmaceuticals (ANIP) United States $0.980B 17.39
Dicerna Pharmaceuticals (DRNA) United States $0.970B 0.00
Cara Therapeutics (CARA) United States $0.965B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.956B 0.00
Adverum Biotechnologies (ADVM) United States $0.955B 0.00
Zymeworks (ZYME) Canada $0.940B 0.00
Principia Biopharma (PRNB) United States $0.936B 0.00
Twist Bioscience (TWST) United States $0.927B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.921B 0.00
WAVE Life Sciences (WVE) Singapore $0.899B 0.00
Retrophin (RTRX) United States $0.893B 0.00
Vericel (VCEL) United States $0.871B 0.00
Arvinas (ARVN) United States $0.808B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.802B 0.00
Intellia Therapeutics (NTLA) United States $0.759B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.723B 34.15
Clovis Oncology (CLVS) United States $0.702B 0.00
Zealand Pharma (ZEAL) Denmark $0.683B 7.99
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Precision BioSciences (DTIL) United States $0.678B 0.00
Cellectis S.A (CLLS) France $0.673B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.659B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.643B 0.00
Cytokineticsorporated (CYTK) United States $0.637B 0.00
DBV Technologies S.A (DBVT) France $0.628B 0.00
Heska (HSKA) United States $0.626B 64.10
Intra-Cellular Therapies (ITCI) United States $0.617B 0.00
Stemline Therapeutics (STML) United States $0.577B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.575B 0.00
Anika Therapeutics (ANIK) United States $0.569B 19.44
Revance Therapeutics (RVNC) United States $0.553B 0.00
MiMedx (MDXG) United States $0.544B 0.00
CytomX Therapeutics (CTMX) United States $0.536B 0.00
Pharming Group (PHGUF) Netherlands $0.492B 0.00
UROGEN PHARMA (URGN) United States $0.454B 0.00
Mesoblast (MESO) Australia $0.452B 0.00
Puma Biotechnology (PBYI) United States $0.450B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
PHARMA MAR SA (PHMMF) Spain $0.436B 0.00
Gritstone Oncology (GRTS) United States $0.397B 0.00
Scholar Rock Holding (SRRK) United States $0.388B 0.00
Prothena (PRTA) Ireland $0.386B 0.00
Biofrontera AG (BFRA) Germany $0.385B 0.00
PDL BioPharma (PDLI) United States $0.375B 8.94
Syros Pharmaceuticals (SYRS) United States $0.371B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
BioDelivery Sciences (BDSI) United States $0.364B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.361B 0.00
Agenus (AGEN) United States $0.361B 0.00
Arcus Biosciences (RCUS) United States $0.361B 0.00
Bellus Health (BLUSF) Canada $0.360B 0.00
Prometic Life Sciences (PFSCD) Canada $0.355B 0.00
Merus (MRUS) Netherlands $0.353B 0.00
Theratechnologies (THERF) Canada $0.351B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.347B 0.00
Albireo Pharma (ALBO) United States $0.342B 0.00
Avid Bioservices (CDMO) United States $0.342B 0.00
Senesco Technologies (ELOX) United States $0.339B 0.00
Starpharma Holdings (SPHRY) Australia $0.336B 0.00
Acorda Therapeutics (ACOR) United States $0.319B 5.61
Kadmon Holdings (KDMN) United States $0.316B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.313B 0.00
Protagonist Therapeutics (PTGX) United States $0.310B 0.00
Sorrento Therapeutics (SRNE) United States $0.308B 0.00
Kindred Biosciences (KIN) United States $0.307B 0.00
Inovio Pharmaceuticals (INO) United States $0.293B 0.00
PHASEBIO PHARMA (PHAS) United States $0.275B 0.00
Cellular Biomedicine (CBMG) United States $0.268B 0.00
Sutro Biopharma (STRO) United States $0.267B 0.00
Dynavax Technologies (DVAX) United States $0.262B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.262B 0.00
Geron (GERN) United States $0.250B 0.00
Athersys (ATHX) United States $0.246B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.244B 0.00
ChromaDex (CDXC) United States $0.242B 0.00
Kamada (KMDA) Israel $0.236B 9.17
ADMA Biologics Inc (ADMA) United States $0.234B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.213B 0.00
Cerecor (CERC) United States $0.213B 0.00
Synlogic (SYBX) United States $0.206B 0.00
Abeona Therapeutics (ABEO) United States $0.206B 0.00
MannKind (MNKD) United States $0.205B 0.00
Five Prime Therapeutics (FPRX) United States $0.204B 0.00
Affimed (AFMD) Germany $0.195B 0.00
POXEL SA FRANCE (PXXLF) $0.194B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.193B 0.00
Mersana Therapeutics (MRSN) United States $0.189B 0.00
Enzo Biochem (ENZ) United States $0.187B 0.00
OSMOTICA PHARM (OSMT) United States $0.186B 0.00
Compugen (CGEN) Israel $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.183B 0.00
Arsanis (XFOR) United States $0.182B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.163B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.161B 0.00
Strongbridge Biopharma (SBBP) United States $0.158B 9.13
XOMA (XOMA) United States $0.152B 0.00
Dyadic (DYAI) United States $0.151B 0.00
Liquidia Technologies (LQDA) United States $0.147B 0.00
OvaScience (MLND) United States $0.143B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
TOCAGEN INC (TOCA) United States $0.141B 0.00
Cue Biopharma (CUE) United States $0.141B 0.00
Adocia (ADOCY) France $0.140B 0.00
Arbutus Biopharma (ABUS) Canada $0.136B 0.00
Northwest Biotherapeutics (NWBO) United States $0.135B 0.00
Aptinyx (APTX) United States $0.126B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.123B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
Seres Therapeutics (MCRB) United States $0.119B 0.00
Alcobra (ARCT) United States $0.119B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.118B 0.00
Menlo Therapeutics (MNLO) United States $0.118B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Novavax (NVAX) United States $0.115B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
Verastem (VSTM) United States $0.112B 0.00
NantKwest (NK) United States $0.110B 0.00
Checkpoint Therapeutics (CKPT) United States $0.105B 0.00
Catalyst Biosciences (CBIO) United States $0.102B 0.00
Fortress Biotech (FBIO) United States $0.100B 0.00
Trevena (TRVN) United States $0.097B 0.00
SESEN BIO, INC (SESN) United States $0.093B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.086B 0.00
VBI Vaccines (VBIV) United States $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.082B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.079B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.079B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.076B 0.00
AquaBounty Technologies (AQB) United States $0.075B 0.00
Curis (CRIS) United States $0.075B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
VTv Therapeutics (VTVT) United States $0.069B 0.00
Unum Therapeutics (UMRX) United States $0.068B 0.00
Organovo Holdings (ONVO) United States $0.067B 0.00
Applied Genetic Technologies (AGTC) United States $0.067B 36.70
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.065B 0.00
Signal Genetics (MGEN) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Antibe Therapeutics (ATBPF) Canada $0.061B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Invo BioScience (IVOB) United States $0.056B 0.00
AIT Therapeutics (AITB) United States $0.055B 0.00
Oncobiologics (OTLK) United States $0.055B 0.00
DiaMedica Therapeutics (DMAC) United States $0.055B 0.00
NewLink Genetics (NLNK) United States $0.054B 0.00
Proteostasis Therapeutics (PTI) United States $0.051B 0.00